Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Stryker Corp
(NY:
SYK
)
328.12
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Stryker Corp
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stryker Gets Price Target Hikes By Analysts Following Upbeat Q1 Results
May 02, 2023
Stryker Corporation (NYSE: SYK) reported better-than-expected earnings for its first quarter and increased its full-year profit outlook.
Via
Benzinga
MGM Resorts To Rally Around 33%? Here Are 10 Other Analyst Forecasts For Tuesday
May 02, 2023
Credit Suisse boosted the price target for KBR, Inc. (NYSE: KBR) from $68 to $71. Credit Suisse analyst Jamie Cook maintained an Outperform rating. KBR shares rose 4.4% to close at $59.16 on Monday.
Via
Benzinga
Pfizer, Ford And 3 Stocks To Watch Heading Into Tuesday
May 02, 2023
With US stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
May 01, 2023
Via
Benzinga
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
May 01, 2023
All three of these companies have seen double-digit increases in their share prices this year.
Via
The Motley Fool
Earnings Preview For Stryker
April 28, 2023
Via
Benzinga
2 Top Stocks to Buy in April and Hold Forever
April 08, 2023
The need for healthcare goods and/or services is here to stay.
Via
The Motley Fool
The Latest Analyst Ratings for Stryker
March 28, 2023
Via
Benzinga
Should Investors Buy This Dividend Growth Stock?
February 12, 2023
This medical devices company is already up in 2023. Should you buy it?
Via
The Motley Fool
Earnings Scheduled For May 1, 2023
May 01, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via
Benzinga
Stryker Expects Good Momentum In 2023 Despite Some Volatility
February 01, 2023
Via
Benzinga
Global Payments, MGM Resorts And 3 Stocks To Watch Heading Into Monday
May 01, 2023
With US stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
These 3 Stocks Might Be Getting a Little Too Expensive
April 30, 2023
These are promising businesses, but you might want to hold off on buying shares -- for now.
Via
The Motley Fool
Microsoft To Rally Around 9%? Here Are 10 Other Analyst Forecasts For Monday
April 03, 2023
RBC Capital raised the price target for Pinterest, Inc. (NYSE: PINS) from $26 to $30. RBC Capital analyst Brad Erickson maintained a Sector Perform rating. Pinterest shares gained 1.5% to $27.68 in...
Via
Benzinga
3 Dividend Champions for Long-Term Income
March 16, 2023
Dividend Champions have grown their dividend payout for at least 25 years in a row. Here are three to keep in mind for long-term income.
Via
InvestorPlace
Portfolio Highlights: Quarterly Movers & Shakers, March 2023
March 14, 2023
High quality stocks that generated strong double-digit gains during the past three months.
Via
Talk Markets
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
January 31, 2023
Via
Benzinga
Stryker's Earnings: A Preview
January 30, 2023
Via
Benzinga
Texas Rep. Michael C. Burgess Sold Up to $500K Worth of Stryker Stock
January 26, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
March 29, 2023
Via
Benzinga
BAX: A “Hospital Stock” To Avoid
February 20, 2023
Baxter International's shares are down nearly 50% over the past three years and have underperformed the broader healthcare industry.
Via
Talk Markets
Interview With David Rolfe of Wedgewood Partners
February 17, 2023
Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe.
Via
The Motley Fool
Stryker's Debt Overview
January 25, 2023
Shares of Stryker Inc. (NYSE:SYK) increased by 10.06% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...
Via
Benzinga
Stryker's Q Guidance System Scores FDA Clearance For Cranial Applications
February 17, 2023
Via
Benzinga
General Motors, Bank of America And 2 Other Stocks Insiders Are Selling
February 07, 2023
The Nasdaq dropped by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Price Reversals From Recent Highs In Stocks
February 06, 2023
Stryker Corp is in a bullish phase on both the daily and weekly charts. Since Friday, the stock had a brick pattern confirmed by Monday’s action.
Via
Talk Markets
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
February 01, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
January 31, 2023
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth,
Via
Benzinga
Earnings Scheduled For January 31, 2023
January 31, 2023
Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023
January 25, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.